Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

HPV infection is most commonly associated with cervical cancer, since roughly 99 per cent of all cervical cancer cases are connected to HPV. Nonetheless, experts warn that HPV is a virus that affects ...

A scientist from Oaxaca in Mexico has made a breakthrough in medicine by completely eliminating the Human Papillomavirus (HPV ...

The Union health ministry plans to introduce the HPV vaccine under the national immunisation programme, aiming to prevent ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Researchers have demonstrated that self-sampling is just as effective as speculum-based testing for HPV detection.

Genital human papillomavirus is the most common sexually transmitted infection in the United States and is thought to be responsible for more than 99% of cervical cancers.

For the first time, Cuba is gearing up to integrate the human papillomavirus (HPV) vaccine into its National Immunization ...

The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are exploring innovative approaches ...